The OSN New York round table discussions are great learning experiences for the audience and the participants. I participated in the round table featured in the cover story of this issue of Ocular Surgery News, so in this commentary I will simply expand on one personal area of interest.
Collagen cross-linking is now FDA approved in the U.S. using the Avedro KXL system. The FDA indication label is for progressive keratoconus and utilizes an epithelium-off approach with continuous ultraviolet light application. Over nearly 15 years, our cornea group at Minnesota Eye Consultants has participated
Uncategorized